Peptides9 min read
Why an LR3 certificate cannot establish human safety
What an IGF-1 LR3 certificate can establish about a sample, and why purity, sterility, biological activity and human safety need different evidence.
Read articleBlog
Research, explained. Explore peptides, supplements and hormone health with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides9 min read
What the missing PEG-MGF human data means for safety claims
Missing human data cannot establish safety or a precise harm rate. Learn what product characterization, exposure studies and clinical follow-up each add.
Read article
Peptides10 min read
How to audit a PEG-MGF citation before believing the headline
Walk through real MGF papers to distinguish exercise observations, human cell cultures, protein measurements and analytical methods from PEG-MGF treatment evidence.
Read article
Peptides8 min read
Two hormone receptors, one medicine: how tirzepatide differs from GLP-1 alone
How tirzepatide's GIP and GLP-1 activity relates to human trial results, and why receptor counts don't rank every clinical benefit.
Read article
Peptides9 min read
Does more growth hormone explain better sleep with ipamorelin?
Growth hormone and sleep are connected, but the human evidence often quoted for ipamorelin comes from a different drug. Learn what was actually measured.
Read article
Peptides9 min read
Semax nasal products: why the formulation is part of the evidence
Why Semax drops, sprays and injections cannot be assumed equivalent—and what animal absorption studies and laboratory testing actually establish.
Read article
Peptides9 min read
Survodutide liver endpoints: what would show meaningful clinical benefit?
Liver fat, biopsy activity and clinical complications answer different questions. Learn what survodutide studies establish—and which benefits need longer trials.
Read article
Peptides9 min read
Does BPC-157 need to be near an injury?
The studies behind BPC-157 do not establish a near-injury injection advantage in people. Route, tissue exposure and healing outcomes need separate comparisons.
Read article
Peptides9 min read
Humanin and memory: what the research has actually tested
Cell survival, mouse behavior, human genetics and blood markers contribute different pieces to Humanin’s memory research.
Read article
Peptides9 min read
Does KPV prevent cancer in people? The evidence gap behind the laboratory claims
A KPV study found benefits in one mouse model and no tumor reduction in another. Neither establishes cancer prevention in people.
Read article
Peptides9 min read
Do antibodies against cagrilintide necessarily mean treatment stops working?
Anti-drug antibodies were detected in cagrilintide research, but detection, neutralization and clinical loss of effect are different findings.
Read article
Peptides9 min read
Eloralintide and selective amylin agonism: what it means
Eloralintide's receptor preference is scientifically interesting. Human trials determine whether it translates into useful benefits.
Read article205–216 of 320 articles